Endovascular Treatment Devices Market to Witness Strong Demand in North America with Favorable Reimbursement and Product Launches

The Endovascular Treatment Devices Market Size is valued at 3486.16 Million in 2024 and is predicted to reach 8398.23 Million by the year 2034 at a 9.4% CAGR during the forecast period for 2025-2034.

Global Endovascular Treatment Devices Market 2025-2034 full Research Repot latest version is now available.

Get Free Access to Demo Report, Excel Pivot and ToC: https://www.insightaceanalytic.com/request-sample/1364

Latest Drivers Restraint and Opportunities Market Snapshot:
Key factors influencing the global Endovascular Treatment Devices market are:
• Rising Prevalence of Cardiovascular Disease
• Increase in Prevalence of Abdominal Aortic Aneurysm (AAA)
• Rising Awareness and Acceptance of Minimally Invasive Procedures

The following are the primary obstacles to the Endovascular Treatment Devices market's expansion:
• High Costs of Endovascular Operations & Devices
• Limitations Associated with the Use of Endovascular Devices

Future expansion opportunities for the global Endovascular Treatment Devices market include:
• Advancement in Endovascular Treatment Technology
• Rising demand for Stent-graft in Aortic Aneurysm Repair Procedures
• Rise in Adoption of Polymer Material in Endovascular Abdominal Aortic Aneurysm Repair Treatment

Key Industry Insights & Findings from the report:
• The growing number of patients seeking treatment for these disorders increases the demand for endovascular treatment devices, which provide less invasive options with faster recovery periods than standard surgery.
• These developments are especially significant in the treatment of abdominal aortic aneurysms (AAA) and thoracic aortic aneurysms (TAA), resulting in improved patient outcomes and a larger market.
• North America is expected to have the largest market share in 2024 due to an increase in surgical procedures and a rise in preference for endovascular devices.
• The high cost can be a substantial impediment for both healthcare professionals and patients, limiting total market adoption.

Market Analysis:
The endovascular treatment devices market is anticipated to witness substantial growth over the forecast period, primarily driven by an aging global population, the increasing incidence of cardiovascular diseases, continuous technological advancements in endovascular therapies, and heightened investments in research and development by key industry participants. Nonetheless, market growth is likely to be constrained by certain challenges, including the high cost associated with endovascular procedures, limited awareness and accessibility in low-income regions, and a shortage of skilled surgeons proficient in performing these complex interventions.

Expert Knowledge, Just a Click Away: https://calendly.com/insightaceanalytic/30min?month=2025-02

List of Prominent Players in the Endovascular Treatment Devices Market:
• Cardinal Health
• Endospan
• Geting AB
• Bosten Scientific Corporation
• Inspire MD
• Japan Lifeline Co., Ltd.
• Medtronic
• Lombord Medical
• Penumbra, Inc.
• Terumo Corporation

Recent Developments:
• In October 2024, BD released an Intraosseous Vascular Access System that provides fast access to the vascular system. This method provides rapid access to the circulatory system for both adult and pediatric patients.
• In September 2024, B. Braun gained FDA authorization for the Introcan Safety 2Deep Access IV Catheter, which aids in multi-access blood management over greater distances.
• In September 2023, Orchestra BioMed gained FDA clearance for an IDE to begin the BACKBEAT pivotal trial of Backbeat CNT for the treatment of hypertension in pacemaker patients.
• Gore announced in January 2024 that the Gore Excluder thoracoabdominal branch end prosthesis (TAMBE) has received FDA clearance. The business claims that this is the first off-the-shelf endovascular treatment designed to address complex aneurysmal problems affecting the visceral aorta.

Endovascular Treatment Devices Market Dynamics:
Market Drivers: Rising Prevalence of Cardiovascular Diseases
The global endovascular treatment devices market is experiencing notable growth, primarily driven by the increasing prevalence of cardiovascular diseases, which account for approximately 17.9 million deaths annually, according to the World Health Organization. Conditions such as coronary artery disease, peripheral artery disease, and acute ischemic stroke are fueling demand for minimally invasive solutions, including stent grafts, catheters, and thrombectomy devices.

Moreover, the rising incidence of abdominal aortic aneurysms is accelerating the adoption of advanced, less invasive procedures such as percutaneous endovascular aneurysm repair (PEVAR) and transcatheter aortic valve replacement (TAVR), which offer advantages like shorter recovery periods and reduced hospitalization. Continuous technological innovation and robust R&D initiatives are further enhancing the safety and effectiveness of these devices, particularly in addressing the healthcare needs of the aging population. Additionally, increased healthcare expenditure in developed economies is supporting broader adoption and market expansion.

Challenges: High Costs and Limited Accessibility
Despite strong growth prospects, the market faces challenges due to the high costs associated with endovascular procedures and devices, which can limit access for both healthcare providers and patients. Furthermore, a shortage of specialized surgeons capable of performing complex endovascular interventions restricts broader clinical adoption. Regulatory hurdles also pose significant barriers, as rigorous approval processes can delay the market entry of new and innovative devices.

Regional Outlook: North America to Lead Market Growth
North America is anticipated to dominate the global endovascular treatment devices market in terms of revenue over the forecast period. This growth is driven by a rising number of surgical interventions and increasing demand for technologically advanced endovascular solutions among healthcare practitioners. Key contributing factors include a high prevalence of obesity and diet-related health conditions, along with continued product launches by leading manufacturers targeting the region. Favorable reimbursement frameworks for endovascular procedures and strong R&D investments are expected to further propel market expansion in North America.

Unlock Your GTM Strategy: https://www.insightaceanalytic.com/customisation/1364

Segmentation of Endovascular Treatment Devices Market-
By Product Type-
• Percutaneous Endovascular Aneurysm Repair (EVAR)
• Fenestrated EVAR
• Aortic Stents Biodegradable Stents
• Self- Expanding Nitinol Stents
• Thoracic Aortic Aneurysm Grafts
• Other Devices
By Procedure-
• Ballon Angioplasty
• Angioplasty With Stent Replacement
• Drug-Eluting Stents Renal Artery Angioplasty and Stenting Carotid Artery
• Thrombosis
• Renal Artery Angioplasty and Stenting
• Transfemoral Carotid Artery Revascularization
• Intravascular Brachytherapy
• Carotid Artery Stenting
By Crop Source
• Pulmonary
• Vascular
• Cardiology Surgery
• Neurology
• Radiology
By Region-
North America-
• The US
• Canada
• Mexico
Europe-
• Germany
• The UK
• France
• Italy
• Spain
• Rest of Europe
Asia-Pacific-
• China
• Japan
• India
• South Korea
• South East Asia
• Rest of Asia Pacific
Latin America-
• Brazil
• Argentina
• Rest of Latin America
Middle East & Africa-
• GCC Countries
• South Africa
• Rest of Middle East and Africa

Read Overview Report- https://www.insightaceanalytic.com/report/global-endovascular-treatment-devices-market-/1364

About Us:
InsightAce Analytic is a market research and consulting firm that enables clients to make strategic decisions. Our qualitative and quantitative market intelligence solutions inform the need for market and competitive intelligence to expand businesses. We help clients gain competitive advantage by identifying untapped markets, exploring new and competing technologies, segmenting potential markets and repositioning products. Our expertise is in providing syndicated and custom market intelligence reports with an in-depth analysis with key market insights in a timely and cost-effective manner.

Contact us:
InsightAce Analytic Pvt. Ltd.
Visit: www.insightaceanalytic.com
Tel : +1 607 400-7072
Asia: +91 79 72967118
info@insightaceanalytic.com

This release was published on openPR.